BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15275708)

  • 1. How and why does radioimmunotherapy work?
    Macklis RM
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1269-71. PubMed ID: 15275708
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radioimmunotherapy in non-Hodgkin's lymphoma. With focus on anti-CD20 treatment].
    de Nully Brown P; Jurlander J; Lindén O; Hansen M
    Ugeskr Laeger; 2005 Oct; 167(41):3867-9. PubMed ID: 16221425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radioimmunotherapy for B-cell lymphoma].
    Tobinai K
    Rinsho Ketsueki; 2006 Jun; 47(6):463-70. PubMed ID: 16862974
    [No Abstract]   [Full Text] [Related]  

  • 4. [Radioimmunotherapy with (90)Y-Ibritumomab tiuxetan].
    Brockmann H; Biersack HJ
    Dtsch Med Wochenschr; 2006 Mar; 131(9):438-40. PubMed ID: 16493567
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiobiology of radioimmunotherapy: targeting CD20 B-cell antigen in non-Hodgkin's lymphoma.
    Hernandez MC; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1274-87. PubMed ID: 15275710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some like it hot!
    Cheson BD
    J Clin Oncol; 2001 Oct; 19(19):3908-11. PubMed ID: 11579110
    [No Abstract]   [Full Text] [Related]  

  • 7. [Targeted destruction of lymphomas with the aid of radioimmunotherapy. Tumor antibodies isotope taxi].
    MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373026
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical development of radioimmunotherapy for B-cell non-Hodgkin's lymphoma.
    Meredith RF; Knox SJ
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S15-22. PubMed ID: 16979433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunotherapy: a new treatment modality for B-cell non-Hodgkin's lymphoma.
    Ghobrial I; Witzig T
    Oncology (Williston Park); 2004 May; 18(5):623-30; discussion 633-4, 637-8, 640. PubMed ID: 15209190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunotherapy for B-cell non-Hodgkin lymphoma.
    Witzig TE
    Best Pract Res Clin Haematol; 2006; 19(4):655-68. PubMed ID: 16997175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunotherapy of non-Hodgkin's lymphoma revisited.
    Goldenberg DM; Sharkey RM
    J Nucl Med; 2005 Feb; 46(2):383-4. PubMed ID: 15695801
    [No Abstract]   [Full Text] [Related]  

  • 12. Radioimmunotherapy with (90)Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network.
    Hohloch K; Zinzani PL; Linkesch W; Jurczak W; Deptala A; Lorsbach M; Windemuth-Kiesselbach C; Wulf GG; Truemper LH
    Bone Marrow Transplant; 2011 Jun; 46(6):901-3. PubMed ID: 20871640
    [No Abstract]   [Full Text] [Related]  

  • 13. 90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.
    Griffiths GL; Govindan SV; Sharkey RM; Fisher DR; Goldenberg DM
    J Nucl Med; 2003 Jan; 44(1):77-84. PubMed ID: 12515879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunotherapy with (131)I-rituximab for patients with relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL).
    Kang HJ; Lee SS; Kim KM; Choi TH; Cheon GJ; Kim WS; Suh C; Yang SH; Lim SM
    Asia Pac J Clin Oncol; 2011 Jun; 7(2):136-45. PubMed ID: 21585693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan.
    Witzig TE; Molina A; Gordon LI; Emmanouilides C; Schilder RJ; Flinn IW; Darif M; Macklis R; Vo K; Wiseman GA
    Cancer; 2007 May; 109(9):1804-10. PubMed ID: 17380530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nuclear medicine and lymphoma].
    Fernández de Sevilla Ribosa A
    Rev Esp Med Nucl; 2006; 25(2):77-9. PubMed ID: 16759612
    [No Abstract]   [Full Text] [Related]  

  • 17. [New trends in non-Hodgkin's lymphoma therapy].
    Mazur G; Wróbel T; Jurczak W; Butrym A
    Postepy Hig Med Dosw (Online); 2006; 60():707-21. PubMed ID: 17245320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.
    Witzig TE; Gordon LI; Cabanillas F; Czuczman MS; Emmanouilides C; Joyce R; Pohlman BL; Bartlett NL; Wiseman GA; Padre N; Grillo-López AJ; Multani P; White CA
    J Clin Oncol; 2002 May; 20(10):2453-63. PubMed ID: 12011122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunotherapy of Non-Hodgkin's lymphoma.
    Britton KE
    J Nucl Med; 2004 May; 45(5):924-5. PubMed ID: 15136647
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted treatment for non-Hodgkin's lymphoma.
    Health News; 2002 May; 8(5):7. PubMed ID: 12132412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.